Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 81, Issue 11, Pages (June 2012)
Volume 77, Issue 9, Pages (May 2010)
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-α produced by renal parenchymal cells  B. Zhang, G. Ramesh, C.C. Norbury, W.B. Reeves 
Volume 81, Issue 11, Pages (June 2012)
Volume 78, Issue 11, Pages (December 2010)
Volume 72, Issue 10, Pages (November 2007)
Volume 79, Issue 1, Pages (January 2011)
Volume 76, Issue 7, Pages (October 2009)
Li-Wen Lai, Kim-Chong Yong, Yeong-Hau H. Lien  Kidney International 
Volume 71, Issue 3, Pages (February 2007)
Volume 79, Issue 9, Pages (May 2011)
Volume 85, Issue 1, Pages (January 2014)
Volume 82, Issue 8, Pages (October 2012)
Volume 74, Issue 7, Pages (October 2008)
Volume 70, Issue 7, Pages (October 2006)
Volume 75, Issue 3, Pages (February 2009)
Volume 53, Issue 4, Pages (April 1998)
Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil  Q. Sun, Z-H. Liu, Z. Cheng, J. Chen,
IL-27 Activates Th1-Mediated Responses in Imiquimod-Induced Psoriasis-Like Skin Lesions  Sayaka Shibata, Yayoi Tada, Yoshihide Asano, Koichi Yanaba, Makoto.
C.-W. Tsai, V.-C. Wu, W.-C. Lin, J.-W. Huang, M.-S. Wu
Volume 75, Issue 2, Pages (January 2009)
Volume 73, Issue 5, Pages (March 2008)
Volume 79, Issue 1, Pages (January 2011)
Volume 70, Issue 2, Pages (July 2006)
Volume 73, Issue 4, Pages (February 2008)
Volume 70, Issue 7, Pages (October 2006)
Paricalcitol attenuates cyclosporine-induced kidney injury in rats
Volume 69, Issue 1, Pages (January 2006)
Volume 85, Issue 4, Pages (April 2014)
Toll-Like Receptor 4 Has an Essential Role in Early Skin Wound Healing
Volume 81, Issue 9, Pages (May 2012)
Gilbert R. Kinsey, Liping Huang, Amy L. Vergis, Li Li, Mark D. Okusa 
Volume 80, Issue 12, Pages (December 2011)
The Loss of MCP-1 Attenuates Cutaneous Ischemia–Reperfusion Injury in a Mouse Model of Pressure Ulcer  Yuki Saito, Minoru Hasegawa, Manabu Fujimoto, Takashi.
Volume 68, Issue 3, Pages (September 2005)
Ischemic and non-ischemic acute kidney injury cause hepatic damage
Volume 72, Issue 3, Pages (August 2007)
Volume 73, Issue 12, Pages (June 2008)
Volume 65, Issue 3, Pages (March 2004)
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin- induced acute kidney injury  K. Negishi, E. Noiri, R. Maeda, D.
Volume 63, Issue 5, Pages (May 2003)
Genetic deficiency of adiponectin protects against acute kidney injury
Volume 85, Issue 4, Pages (April 2014)
An unusual cause of acute renal failure
Volume 71, Issue 7, Pages (April 2007)
Volume 76, Issue 7, Pages (October 2009)
Volume 72, Issue 2, Pages (July 2007)
Volume 75, Issue 5, Pages (March 2009)
Volume 83, Issue 6, Pages (June 2013)
Volume 79, Issue 2, Pages (January 2011)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 74, Issue 1, Pages (July 2008)
Role of the T-cell receptor in kidney ischemia–reperfusion injury
Volume 60, Issue 6, Pages (December 2001)
Volume 85, Issue 1, Pages (January 2014)
Volume 63, Issue 1, Pages (January 2003)
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
H. Raffi, J.M. Bates, Z. Laszik, S. Kumar  Kidney International 
Endothelial cell activation
Volume 58, Issue 4, Pages (October 2000)
Inflammatory cells in ischemic acute renal failure
Volume 77, Issue 11, Pages (June 2010)
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.
Volume 62, Issue 1, Pages (July 2002)
Volume 58, Issue 5, Pages (November 2000)
Volume 65, Issue 3, Pages (March 2004)
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
J. Ma, A. Weisberg, J.P. Griffin, D.E. Vaughan, A.B. Fogo, N.J. Brown 
Volume 69, Issue 11, Pages (June 2006)
Presentation transcript:

S1P1-selective agonist, SEW2871, ameliorates ischemic acute renal failure  Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai  Kidney International  Volume 69, Issue 9, Pages 1601-1608 (May 2006) DOI: 10.1038/sj.ki.5000360 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Mouse plasma creatinine (Cr) levels of control (closed bars), SEW2871 treatment only (gray bars); I/R injury (open bars), and I/R+SEW2871 treatment (striped bar). Values are means±s.e. I/R injury increased plasma Cr level after 24 h (##P<0.01 vs control, n=6) and SEW2871 significantly reduced this elevation (**P<0.01 vs I/R, n=6). Kidney International 2006 69, 1601-1608DOI: (10.1038/sj.ki.5000360) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Histology examination of the kidney (hematoxylin and eosin stain, original magnification: × 400). (a) SEW2871 treatment per se without I/R injury did not cause significant injury or leukocyte accumulation in the kidney. (b) There was severe tubular damage with neutrophil infiltration (white arrow) in the kidney 24 h after I/R injury, (c) while SEW2871-treated kidney showed a significant reduction in I/R-induced tubular damage and neutrophil infiltration. (See Figure S1 for color pictures.) Kidney International 2006 69, 1601-1608DOI: (10.1038/sj.ki.5000360) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 Effects of SEW2871 on acute tubular necrosis scores and infiltration of neutrophils and macrophages. Pretreatment with (a) SEW2871 reduced acute tubular necrosis scores and (b) infiltrating neutrophils and macrophages 24 h after I/R injury. HPF: high-powered field. n=6 per group, **P<0.01 vs I/R. Kidney International 2006 69, 1601-1608DOI: (10.1038/sj.ki.5000360) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 4 SEW2871 reduces infiltrating macrophages in ischemic kidneys. (a–c) Immunofluorescent staining (red) of macrophages and (d) CD4+ T cells using anti-F4/80 and anti-CD4 antibodies, respectively (original magnification: × 400). (a) There were resident macrophages in untreated kidney. (b) Macrophages increased markedly 24 h after I/R injury and (c) pretreatment with SEW2871 reduced the number of macrophages. (d) CD4+ T cells (one in the middle) were rarely seen in the kidney 24 h after I/R injury. (See Figure S2 for color pictures.) Kidney International 2006 69, 1601-1608DOI: (10.1038/sj.ki.5000360) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 5 Effects of SEW2871 on mRNA abundance on TNF-α and adhesion molecules. Renal mRNA abundance of TNF-α, P-selectin, E-selectin, ICAM-1, and VCAM-1 in mice with I/R injury (open bars), I/R and SEW2871 treatment (3rd bar), SEW2871 treatment only (gray bars), and without treatment (closed bars). mRNA levels are expressed as percent relative to a baseline of 100% and normalized with dynactin mRNA. N=6–8, *P<0.05, and **P<0.01, vs control; #P<0.05 and ##P<0.01 vs I/R. Kidney International 2006 69, 1601-1608DOI: (10.1038/sj.ki.5000360) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 6 SEW2871 reduces I/R induced ICAM expression. (a) Immunofluorescent staining of ICAM-1 in the kidney shows minimal immunoreactivity in baseline kidney, (b) markedly increased immunoreactivity in peritubular capillary 24 h after I/R injury, (c) and attenuation of immunoreactivity by SEW2871 treatment. Original magnification: × 400. Bar=0.05 mm. (See Figure S3 for color pictures.) Kidney International 2006 69, 1601-1608DOI: (10.1038/sj.ki.5000360) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 7 SEW2871 reduces I/R induced P-selectin expression. (a) Immunofluorescent staining of P-selectin (red) shows minimal immunoreactivity in baseline kidney, (b) increased immunoreactivity in peritubular capillary 24 h after I/R injury, (c) and attenuation of immunoreactivity by SEW2871 treatment. (d) The P-selectin (red) was mainly expressed in the endothelial cells of peritubular capillaries as shown by double staining using antibodies against von Willebrand factor (green). Original magnification: × 400. Kidney International 2006 69, 1601-1608DOI: (10.1038/sj.ki.5000360) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 8 SEW2871 reduces I/R induced TNF-α expression. Immunofluorescent staining of TNF-α (red) and THP specific for the thick ascending limb, staining green. (a) There was minimal TNF-α immunoreactivity in untreated kidney. (b) After I/R injury, TNF-α immunoreactivity was markedly increased in the tubular epithelial cells without overlap with THP immunoreactivity. (c) SEW2871 treatment decreased TNF-α immunoreactivity significantly. (b, c) Neither I/R injury nor SEW2871 treatment had effects on THP immunoreactivity. Original magnification: × 400. Kidney International 2006 69, 1601-1608DOI: (10.1038/sj.ki.5000360) Copyright © 2006 International Society of Nephrology Terms and Conditions